Podcasts about medicine committee

Dr Kelly Kelleher visits the studio as we consider the current state of child health care in America. He recently served on a National Academy of Medicine Committee tasked with identifying opportunities for reform… and recommending evidence-based solutions for improvement. Tune in to learn more!

In this, the second installment of the series recapping the NHCA 2025 Conference, we have an incredible presentation from Colleen Le Prell, PHD. This is an edit version of her contribution to the Updates in Music Audiology workshop. The NHCA audience knows her as a recent past present of the organization, and a frequent presenter at the conferences. We know her as a dear friend who continually inspires us to a reach the highest possible academic rigor in our work. Dr. Le Prell is the Emilie and Phil Schepps Professor of Hearing Science, Head of the Department of Speech, Language, and Hearing, and Co-Director for the Clinical and Translational Research Center at UT Dallas. She has received research funding from the National Institutes of Health (NIH), the Department of Defense (DoD), philanthropic foundations, and industry, for research on prevention of noise-induced hearing loss. She is the academic leader for the DoD Hearing Center of Excellence Pharmaceutical Interventions for Hearing Loss work group and an invited member of the National Academies of Sciences, Engineering, and Medicine Committee on Meaningful Outcome Measures in Adult Hearing Health Care.  She is the Chair of the NIH Center for Scientific Review Auditory System Study Section, and serves on the Centers for Disease Control and Prevention National Occupational Research Agenda Hearing Loss Prevention Cross Sector Council and the World Health Organization Make Listening Safe working group. Brief music clips heard in this episode are from a live performance of Osler Circle, a Beatles cover band based in Philadelphia. This is used for educational purposes and while the recording is ours to use, we do not own the rights to the original song, "Day Tripper", and that all rights belong to the respective copyright holders.

Dr. Michael Demetriou is Director of the National Multiple Sclerosis Society Designated Comprehensive Care Clinic, Professor of Neurology, and Chief of the Division of Multiple Sclerosis and Neuroimmunology at the University of California, Irvine (UCI) School of Medicine. In his research, Mike studies the biological roles of complex sugars called glycans. Glycans are mostly found outside of cells and on cell surfaces. They form a dense forest around the surface of cells and can interact with other proteins to regulate cellular function through interactions with other cell surface proteins. Mike's lab is interested in how these cell surface glycans influence biology and disease, particularly in autoimmune diseases like multiple sclerosis (MS) and in diseases like cancer where there are commonly abnormalities in these glycans. Mike is also a big fan of the Toronto Maple Leafs hockey team. While he doesn't play hockey himself anymore, he loves watching professional hockey games and seeing the Maple Leafs play whenever they are in town. He was awarded his MD and his PhD in molecular genetics from the University of Toronto. Mike completed his residency in Neurology at the University of Toronto as well and completed his postdoctoral fellowship at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Toronto. He has received a variety of awards and honors in his career, including being named a Fellow of the Royal College of Physicians and Surgeons in Canada. In addition, he has received UCI's College of Medicine Committee on Research Award, the Health Science Partners Research Award, the Academic Senate Distinguished Service Award, and the Dr. S. Van Den Noort Research Award for Junior Faculty. In our interview, Mike shares more about his life and science.

This week, Jeremy welcomes Kathleen Sheehan, Vice President of Public Policy at The ALS Association, for an update on the National Academies of Sciences, Engineering, and Medicine Committee's action plan to make ALS livable and to accelerate the search for treatments. Learn more about the NAS working group at https://www.nationalacademies.org/our-work/amyotrophic-lateral-sclerosis-accelerating-treatments-and-improving-quality-of-lifeThis episode is brought to you by The ALS Association in partnership with CitizenRacecar.

Dr. Moupali Das, MD, MPH, is Executive Director, HIV Clinical Research, in the Virology Therapeutic Area, at Gilead Sciences ( https://www.gilead.com/ ) , where she leads the pre-exposure prophylaxis (PrEP) clinical drug development program, including evaluating the safety and efficacy of a long-acting, twice yearly, subcutaneous injection being studied for HIV prevention. Her responsibilities also include expanding the populations who may benefit from PrEP. Dr. Das has led high-performing teams in academic medicine, public health, implementation science, and cross-functionally in drug development. She has successfully helped develop, implement, and evaluate how to better test, link to care, increase virologic suppression, and improve quality of life for people with HIV, and to prevent HIV in those who may benefit from PrEP. During the COVID19 pandemic, Dr. Das assisted her colleagues in the COVID-19 treatment program, leading the evaluation of a COVID-19 treatment for use in pregnant women and children from the compassionate use program. After completing her undergraduate degree in Biochemical Sciences at Harvard College, medical school and internal medicine residency training at Columbia University and New York Presbyterian Hospital, Dr. Das came to University of California, San Francisco (UCSF) for fellowship training in Infectious Diseases and to University of California, Berkeley for her MPH in Epidemiology. She cared for HIV patients at San Francisco General's storied Ward 86 clinic and attended on the inpatient ID Consult Service. She is recognized internally and externally for her expertise in epidemiology, public health, advocacy, and community engagement. Prior to joining Gilead, Dr. Das developed a novel population-based indicator, community viral load (CVL), to evaluate the impact of treatment as prevention. Her CVL research was the basis for using viral suppression to evaluate the effectiveness of President Barack Obama's National HIV/AIDS Strategy. She also served on the Institute of Medicine Committee on Data Systems for Monitoring HIV/AIDS care. Dr. Das has authored over 60 manuscripts, presented at scientific conferences, policy forums, and for community and advocacy organizations. Her publications have been highly cited and garnered significant press coverage including in The New York Times and Nature. Dr. Das appears in her personal capacity and any views expressed are her own. Support the show

The Sunshine State leads the way in protecting children. Constitutional expert, lawyer, author, pastor, and founder of Liberty Counsel Mat Staver discusses the important topics of the day with co-hosts and guests that impact life, liberty, and family. To stay informed and get involved - visit www.LC.org   

Episode 13 of NucleCast features the Honorable William C. Ostendorff! Bill Ostendorff has a distinguished career as an engineer, legal counsel, policy advisor, and naval officer. He currently serves as a nuclear industry adviser for several companies. In addition, he co-chairs a National Academies of Science, Engineering and Medicine Committee on Risk Analysis for Nuclear War and Nuclear Terror. He also serves as a member of the Intelligence Community Studies Board at the National Academies which advises the Director of National Intelligence on Science and Technology. He served as Principal Deputy Administrator at the National Nuclear Security Administration (NNSA) in the Bush administration (2007-2009) and as a Commissioner at the US Nuclear Regulatory Commission (2010-2016) in the Obama administration.

The world's swimming governing body has banned trans women from competing in female competitions.Trans women are only allowed to compete if they started transitioning before the age of 12.Instead FINA is going to create an open category for trans women to compete in.FINA Sports Medicine Committee vice-chair Dr Dave Gerrard joined Heather du Plessis-Allan.LISTEN ABOVE

Rochelle Frank MD received her medical degree at University of California San Diego, attended Neurology residency at the University of North Carolina Chapel Hill and received fellowship training in Neurophysiology at University of California Davis.  She has been an Associate Professor of Neurology and Neurology Clerkship Director at California Northstate University College of Medicine since 2016.  Before that time she worked for 18 years as a general Neurologist at Kaiser Permanente in Roseville California.   She is board certified in Neurology and Clinical Neurophysiology and received additional board certifications in Integrative Medicine from the ABoIM (American Board of Integrative Medicine) in 2016 and the ABIHM in 2012.  She is the current Vice Chair and Chair Elect of the American Academy of Neurology Neurohealth and Integrative Neurology Section. Her research interests include Integrative Medicine, Functional Neurologic Disorder and medical student wellness.  She has also created many programs in physician and medical student wellness, is currently Chair of the CNU COM Student Wellness Committee, member of the Sierra Sacramento Valley Medical Society Joy of Medicine Committee and recent member of the AAN Live Well ELA Committee.   Unlock Bonus content and get the shows early on our Patreon Follow us or Subscribe: Apple Podcasts | Google Podcasts | Stitcher | Amazon  | Spotify --- Show notes at https://rxforsuccesspodcast.com/101 Report-out with comments or feedback at https://rxforsuccesspodcast.com/report Music by Ryan Jones. Find Ryan on Instagram at _ryjones_, Contact Ryan at ryjonesofficial@gmail.com

Hello everyone! Welcome to Season 2 of the Before the Coats podcast hosted by the Culture of Medicine Committee in Berkeley's chapter of American Medical Student Association (AMSA)! In our first episode of the season, upperclassmen Christine Chau and Kaitlyn Lee help freshman Aayush Pagaria navigate being pre-med at UC Berkeley! Christine and Kaitlyn discuss pre-med culture such as academic burnout, their experiences with upper and lower division classes, extracurriculars, and much more. The fifth episode is out now on Spotify, Google Podcasts, Breaker, Anchor, Pocket Casts, RadioPublic, and Apple Podcasts! Be sure to fill out our feedback/Q&A form, where you can ask our hosts and guests any questions for future episodes and suggest topics you would like us to discuss on the podcast: https://tinyurl.com/BeforeTheCoatsQuestionnaire

Marcus interviews Dr. Sharon Pappas, PhD, RN, NEA-BC, FAAN, Chief Nurse Executive of Emory Health. Dr. Pappas shares her journey into nursing and the lessons she has learned throughout her career. They discuss the current state of nursing in the country, what leaders can do to create a winning culture and how leaders can listen and encourage staff. Key topics:[1:37] Dr. Sharon Pappas' journey into becoming a nurse[6:00] What has changed at the bedside within Dr. Pappas' 40 year career?[10:38] Dr. Pappas shares a few times where she was there for someone or when someone was there for her[15:44] How Dr. Pappas conveys a compassionate culture with her nurses at Emory[21:02] Where Dr. Pappas learned about leadership[25:44] What piece of art would Dr. Pappas take with her on a desert island?[29:25] What fictional character would Dr. Pappas be for a day?[31:19] What is the message that Dr. Pappas would like to convey to the world?Resources for you:Learn more about Emory Healthcare: https://www.emoryhealthcare.org/Connect with Marcus on Facebook: https://www.facebook.com/MarcusEngelSpeaker/Connect with Marcus on LinkedIn: https://www.linkedin.com/in/marcusengel/Subscribe to the podcast through Apple: https://bit.ly/MarcusEngelPodcastSubscribe to the podcast through Spotify: https://bit.ly/Spotify-MarcusEngelPodcastLearn more about Dr. Sharon Pappas:Sharon H. Pappas, RN, PhD, NEA-BC, FAAN is the Chief Nurse Executive for Emory Healthcare. She is a member of Emory Healthcare and the Woodruff Health Science Center's senior leadership teams and is responsible for nursing practice across Emory's hospitals, ambulatory care, and post-acute agencies. With four Emory Healthcare hospitals designated as Magnet®, she works to establish this same nursing excellence as a distinctive competency throughout Emory Healthcare.Dr. Pappas completed her PhD at the University of Colorado, Denver College of Nursing with research focus on clinical and financial outcomes that are sensitive to nursing. She holds a Master of Science in Nursing Administration from Georgia College, School of Nursing and a Bachelor of Science in nursing, from the School of Nursing, Medical College of Georgia.Dr. Pappas has authored numerous articles for peer-reviewed journals and done numerous conference presentations throughout her career focusing on the role nurses and the nursing environment play in patient safety and hospital costs. She also serves as professor for the Nell Hodgson Woodruff School of Nursing. Dr. Pappas is a member of Sigma Theta Tau, International, the American Nurses Association, and the American Organization for Nursing Leadership where she served as a Board member and currently represents AONL on the Commission on Magnet® for the American Nurses Credentialing Center. Sharon is a Fellow in the American Academy of Nursing where she is past chair of the Expert Panel on Building Health System Excellence. Dr. Pappas served on the National Academy of Science, Engineering, & Medicine Committee on Systems Approaches to Improve Patient Care by Supporting Clinician Well-being.Dr. Pappas is married to Greg Pappas and has two daughters, Kristen and Ruth.Date: 01/25/2022Name of show: Compassion & Courage: Conversations in HealthcareEpisode title and number: Episode 30 – Dr. Sharon Pappas: Nursing - A Profession That Teaches People How to Live

For video content and additional info: https://youtu.be/ZxynnHmR-KI Today, I'm very excited to be sitting across from Dr. Anthony Biglan. Dr. Biglan is a senior scientist at the Oregon Research Institute that partners with others around the world to promote behavior change toward sustainable health and wellbeing. Their emerging areas right now include genetics, health economics, Alzheimer's Disease and opioid addiction. Tony is Co-Director of Promise Neighborhood Research Consortium, a community-based network that works to improve wellbeing in high-poverty neighborhoods. For over 30 years, he's been conducting research on the development and prevention of child and adolescent problem behaviors. He is former president of the Society for Prevention Research, dedicated to advancing scientific investigation focused on the causes and prevention of social, physical and mental health, and academic problems. He was a member of the Institute of Medicine Committee on Prevention and of Oregon's Alcohol and Drug Policy Commission. His books, the Nurture Effect: How the Science of Human Behavior Can Improve Our Lives and Our World and Rebooting Capitalism: How We Can Forge a Society That Works for Everyone. are a culmination of his life's work that lay the framework for a model of societal change. He has also created the nonproft Values to Action to advance the reforms he calls for in his book Rebooting Capitalism, where solution-focused action circles are created around societal issues where we apply the principles of contextual behavioral science. If there is a problem you see in our society or in your community, an Action Circle is the way that you can address it to achieve concrete results. Join Values to Action.org and contribute just $47 to become a lifetime member.

Dr. Fariha Shafi is is the Co-Founder of the ResetMD Podcast! She is an Associate Professor of Medicine at the University of Missouri Kansas City-School of Medicine. She is a Fellow of the American College of Physicians (ACP) and is an ACP Well-Being Champion, Chair of both the Wellness Committee and the Women in Medicine Committee of the Missouri Chapter of the ACP. She has served as the AMWA Mentor at the SOM for many years. She has a career in academic medicine at UMKC, serving in various leadership roles including Chairing the School of Medicine's Diversity Equity and Inclusion Council for eight years and being named as an inaugural “Noback” Docent. Dr. Shafi has been featured on podcasts such as KevinMD and Medicine Mentors. She is a busy mom of two, a full time physician and a heavily involved community leader. In this episode we discuss a time where she felt stuck, both with the struggle of being a mom and a professional and with trying to find the right venue for her passions. A conversation at her chapter ACP meeting and making peace with guilty feelings changed all that and gave her energy. Listen in to see how this worked for her an could work for you too. Pearls of Well-Being Wisdom: 1. Medicine is part of your life, not your entire life. 2. Always find something that fulfills you outside of medicine. 3. Journal your feelings- during times of success as well as the times when you are upset. Refer back to your successes more often. 4. Give back.

Tony Biglan, Ph.D., is a Senior Scientist at Oregon Research Institute and Co-Director of the Promise Neighborhood Research Consortium. For the past thirty years, he has conducted research in the development and prevention of child and adolescent problem behavior. He is a former president of the Society for Prevention Research and was a member of the Institute of Medicine Committee on Prevention. As a member of Oregon's Alcohol and Drug Policy Commission, he has helped to develop a strategic plan for implementing comprehensive evidence-based interventions throughout Oregon. Dr. Biglan is the founder of Values to Action, an organization dedicated to evolving more nurturing societies. He has helped to identify effective family, school, and community interventions to prevent the most common and costly problems of childhood and adolescence around the world. Working to advance the reforms called for in his most recent book, Rebooting Capitalism: How We Can Forge a Society That Works for Everyone, Dr. Biglan advocates for the creation of  “Action Circles,” small groups of like-minded people who devote as little as 15 minutes a day to come together to study a problem in an effort to devise a solution. In this episode, you'll learn… A powerful lesson about not taking the criticism and advice of others too seriously. About the tensions between administration and scientists and the balance of doing what it takes to gain funding while remaining true to callings and passions. About the groundbreaking work done from the 1970s to the present at Oregon Research Institute in Eugene, OR and the creation of the first behavior change clinic in Oregon. That being politically and socially active and fighting for justice are possible and needed, even while remaining dedicated to science and research work and keeping a good balance, including family and leisure. The importance of science support people and participatory democracy. That serendipity and luck can play a part in success and that there are many paths, not just one “right” one. The importance of idleness. About some frustrations with NIH and the problem of addressing individual issues instead of the whole social context. About prevention and the concept of “Action Circles.” Tips from the episode  On the weight of the opinions of others, even older mentors and those in leadership positions… Learn from Dr. Biglan's personal account of having suicidal thoughts because his dissertation methodology was judged so harshly. Be encouraged by his later discovery that the very same dissertation became one of his greatest life accomplishments and his name is now attached to the concept of “the Biglan Model” because of it. Remember his advice: If you're working on your dissertation and they tell you it's no good or not worthwhile and so on, just remember they could be mistaken. This, of course, applies to most things in life, not just dissertation work. On participatory democracy… Support people are vital to everything. Honoring them and giving them a voice will only improve success. Listen to colleagues who hold different priorities than yours and release some power and control. On gaining funding while holding on to personal passions and what's important … A lot depends on luck or serendipity as to who you meet or how fate happens to put you in the right place at the right time. Having a good system and good support people for writing grants is important. Scientists also have a responsibility to fight for things to get done. As Dr. Biglan says,  It's imperative that scientists speak up and not simply wait outside the halls of the federal government and hope that somebody will do the right RFA. On making use of idleness… Dedicate time and thought to your passions during your “idle” time. Let your mind focus on what is important to you. Follow Dr. Biglan's example of getting up early in the morning to write what he wants, not what work requires. Spend time during vacations or days off so that there is no tension or guilt about neglecting work. On implementing reform and Values to Action… If you are concerned about the state of the world and you're not sure what to do about it, join or create an Action Circle at Values to Action. To learn about implementing reforms, read Rebooting Capitalism: How We Can Forge a Society That Works for Everyone. We all need to look up from our work and be addressing those problems.     Links from the episode: Website Nurture Effect: http://www.nurtureeffect.com/ Website Values to Action: https://www.valuestoaction.org/ Dr. Biglan's books on Amazon Twitter: https://twitter.com/ABiglan LinkedIn: https://www.linkedin.com/in/anthony-biglan-093b7710/ French and Raven Bases of Social Power Bertrand Russell Essay Psychological Bulletin Article on Stress Research Matters Podcast is hosted by Jason Luoma, who can be found on Twitter @jasonluoma or Facebook at: facebook.com/jasonluomaphd. You download the podcast through iTunes, Stitcher, or Spotify. Reach out with suggestions, questions, or comments to researchmatterspod@gmail.com

Dr. Doreen DeFaria Yeh, MD, Associate Director, Massachusetts General Hospital (MGH) Adult Congenital Heart Disease Program, Co-Director, MGH Cardiovascular Disease and Pregnancy Program, and Program Director, Cardiovascular Disease Fellowship discusses her recent presentation “Strategies for Recruiting and Supporting Cardiology Fellows in Training from Diverse Backgrounds” at the 2021 American College of Cardiology's annual scientific meeting. Featured as part of a larger discussion around cultivating an antiracist culture in cardiovascular medicine, Dr. DeFaria's timely research aims to increase inclusion within the industry. #ACC21 Dr. DeFaria joined the MGH Cardiology staff in 2010 and served as the Subspecialty Core Educator in Cardiology for the Internal Medicine Residency Program for seven years before assuming the Associate Program Director role of the Cardiovascular Fellowship and now serves at the Program Director of the Cardiovascular Disease Fellowship Program.Doreen is the Associate Director of the MGH Adult Congenital Heart Disease (ACHD) Program, Co-Director of the MGH Cardiovascular Disease and Pregnancy Program, and participates in a number of departmental committees including the Department of Medicine Education Council, the Diversity and Inclusion Board, and the Women in Medicine Committee. She presently serves as the Chair of the Internal Medicine Resident Selection Committee, Faculty Chair of the Women in Medicine Trainees Council, and Associate Program Director for the Harvard ACHD Senior Fellowship. Dr. DeFaria Yeh was selected as an American College of Cardiology Emerging Faculty in 2012 and has received the Eleanor and Miles Shore Award through Harvard Medical School, the Clinician Teacher Development Award through the MGPO and Center for Diversity and Inclusion, the MGH Cardiology Division's Clinical Scholar Award in 2016, and is a multiple recipient of the Brian A. McGovern Memorial Award for Excellence in Clinical Care and Teaching. She has co-directed a number of continuing medical education courses including the MGH ACHD Course for General Practitioners, as well as the MGH Multidisciplinary Care of the Pregnant Patient with Heart Disease Course. She will serve as Chair of the American Heart Associations Laennec Post-Graduate Education Committee and speaks nationally on topics including ACHD, cardio-obstetrics and echocardiography.

At least 3.4+ Million Live with Epilepsy in the U.S.2National Neurology Expert Offers Immediate Steps to Mitigate Deadly Risks, ReduceRelated Healthcare Costs and BurdenGUEST:  Dr. James Wheless, Professor and Chief of Pediatric Neurology, Le Bonheur Chair in Pediatric Neurology, University of Tennessee Health Science CenterBackground:Epilepsy is a disorder of the brain that is characterized by seizures.3 Seizures can be debilitating and even life threatening.4 Just one convulsive seizure is a potentially shattering event that increases the risk of significant health consequences, including physical injury and cognitive decline.5,6,7 Although epilepsy is widely recognized, few understand it – even those who know someone with the disorder.1 And this misunderstanding causes a stigma that makes it harder to treat,1 while the number of adults and children challenged by epilepsy in the U.S. is increasing.2Freedom from seizures is the ultimate goal in epilepsy treatment.8 Yet missed doses are a common occurrence that can get in the way of achieving it. For most people with this condition, it's a question of when, not if they will miss a dose of their medication. In fact, 71% of epilepsy patients surveyed have missed at least 1 dose.9 And, almost 50% report that a missed dose of medication was followed by a subsequent seizure.9 Poor seizure control means a higher likelihood of emergency room visits and greater healthcare costs.10 Yet many with epilepsy may be reluctant to discuss their struggles even with their doctor.11Dr. James Wheless, Professor and Chief of Pediatric Neurology, Le Bonheur Chair in Pediatric Neurology, University of Tennessee Health Science Center will help educate your viewers about epilepsy, including the crucial role of individual lifestyle in treatment, and advances in epilepsy management that will help people living with epilepsy achieve seizure freedom.More information can be found at www.epilapsey.comMore About Dr. James WhelessDr. Wheless is Professor and Chief of Pediatric Neurology and the Le Bonheur Chair in Pediatric Neurology at the University of Tennessee Health Science Center in Memphis. He also serves as Director of the Neuroscience Institute and the Le Bonheur Comprehensive Epilepsy Program for the Le Bonheur Children's Hospital.Dr. Wheless is a paid consultant on behalf of Eisai Inc.REFERENCEHerrmann LK, et al. Epilepsy misconceptions and stigma reduction: Current status in Western Countries. Epilepsy Behav. 2016;60:165-173.Zack MM, Kobau R. National and State Estimates of the Numbers of Adults and Children with Active Epilepsy — the United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:821–825.Institute of Medicine Committee on the Public Health Dimensions of the Epilepsies. Summary.  Epilepsy Across the Spectrum: Promoting Health and Understanding. England MJ, Liverman CT, Schultz AM, Strawbridge LM, editors. Washington, DC: National Academies Press; 2012.Harden C, et al. Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors:  Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsy Currents. 2015;17(3):180-187.Friedman DE, et al. Recurrent seizure-related injuries in people with epilepsy at a tertiary epilepsy center: A 2-year longitudinal study. Epilepsy Behav. 2010;19(3):400-404.Thompson PJ, Duncan JS. Cognitive decline in severe epilepsy. Epilepsia. 2005;45(11):1780-1787.Berg AT, et al. Mortality risks in new-onset childhood epilepsy. Pediatrics. 2013;132(1):124-131St. Louis, EK. Minimizing AED Adverse Effects: Improving Quality of Life in the Interictal State in Epilepsy Care. Current Neuropharmacol. 2009;7:106-114.Cramer JA, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav. 2002;3:338-342.Divino V, Petrilla AA, Bollu V, et al. Clinical and economic burden of breakthrough seizures. Epilepsy Behav. 2015;51:40-47.Buelow J, Miller W, Fishman J. Development of an Epilepsy Nursing Communication Tool: Improving the Quality of Interactions Between Nurses and Patients with Seizures. Jour of Neurosci Nurs. 2018;50(2):74-80.

At least 3.4+ Million Live with Epilepsy in the U.S.2National Neurology Expert Offers Immediate Steps to Mitigate Deadly Risks, ReduceRelated Healthcare Costs and BurdenGUEST:  Dr. James Wheless, Professor and Chief of Pediatric Neurology, Le Bonheur Chair in Pediatric Neurology, University of Tennessee Health Science CenterBackground:Epilepsy is a disorder of the brain that is characterized by seizures.3 Seizures can be debilitating and even life threatening.4 Just one convulsive seizure is a potentially shattering event that increases the risk of significant health consequences, including physical injury and cognitive decline.5,6,7 Although epilepsy is widely recognized, few understand it – even those who know someone with the disorder.1 And this misunderstanding causes a stigma that makes it harder to treat,1 while the number of adults and children challenged by epilepsy in the U.S. is increasing.2Freedom from seizures is the ultimate goal in epilepsy treatment.8 Yet missed doses are a common occurrence that can get in the way of achieving it. For most people with this condition, it's a question of when, not if they will miss a dose of their medication. In fact, 71% of epilepsy patients surveyed have missed at least 1 dose.9 And, almost 50% report that a missed dose of medication was followed by a subsequent seizure.9 Poor seizure control means a higher likelihood of emergency room visits and greater healthcare costs.10 Yet many with epilepsy may be reluctant to discuss their struggles even with their doctor.11Dr. James Wheless, Professor and Chief of Pediatric Neurology, Le Bonheur Chair in Pediatric Neurology, University of Tennessee Health Science Center will help educate your viewers about epilepsy, including the crucial role of individual lifestyle in treatment, and advances in epilepsy management that will help people living with epilepsy achieve seizure freedom.More information can be found at www.epilapsey.comMore About Dr. James WhelessDr. Wheless is Professor and Chief of Pediatric Neurology and the Le Bonheur Chair in Pediatric Neurology at the University of Tennessee Health Science Center in Memphis. He also serves as Director of the Neuroscience Institute and the Le Bonheur Comprehensive Epilepsy Program for the Le Bonheur Children's Hospital.Dr. Wheless is a paid consultant on behalf of Eisai Inc.REFERENCEHerrmann LK, et al. Epilepsy misconceptions and stigma reduction: Current status in Western Countries. Epilepsy Behav. 2016;60:165-173.Zack MM, Kobau R. National and State Estimates of the Numbers of Adults and Children with Active Epilepsy — the United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:821–825.Institute of Medicine Committee on the Public Health Dimensions of the Epilepsies. Summary.  Epilepsy Across the Spectrum: Promoting Health and Understanding. England MJ, Liverman CT, Schultz AM, Strawbridge LM, editors. Washington, DC: National Academies Press; 2012.Harden C, et al. Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors:  Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsy Currents. 2015;17(3):180-187.Friedman DE, et al. Recurrent seizure-related injuries in people with epilepsy at a tertiary epilepsy center: A 2-year longitudinal study. Epilepsy Behav. 2010;19(3):400-404.Thompson PJ, Duncan JS. Cognitive decline in severe epilepsy. Epilepsia. 2005;45(11):1780-1787.Berg AT, et al. Mortality risks in new-onset childhood epilepsy. Pediatrics. 2013;132(1):124-131St. Louis, EK. Minimizing AED Adverse Effects: Improving Quality of Life in the Interictal State in Epilepsy Care. Current Neuropharmacol. 2009;7:106-114.Cramer JA, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav. 2002;3:338-342.Divino V, Petrilla AA, Bollu V, et al. Clinical and economic burden of breakthrough seizures. Epilepsy Behav. 2015;51:40-47.Buelow J, Miller W, Fishman J. Development of an Epilepsy Nursing Communication Tool: Improving the Quality of Interactions Between Nurses and Patients with Seizures. Jour of Neurosci Nurs. 2018;50(2):74-80.

In this episode of Better Thinking, Nesh Nikolic speaks with Dr Anthony Biglan about his book, The Nurture Effect, which offers evidence-based interventions that can prevent many of the psychological and behavioral problems that plague our society. Anthony Biglan, Ph.D., is a Senior Scientist at Oregon Research Institute. He has been conducting research on the development and prevention of child and adolescent problem behavior for the past 30 years. His work has included studies of the risk and protective factors associated with tobacco, alcohol, and other drug use; high-risk sexual behavior; and antisocial behavior. He has conducted numerous experimental evaluations of interventions to prevent tobacco use both through school-based programs and community-wide interventions. And, he has evaluated interventions to prevent high-risk sexual behavior, antisocial behavior, and reading failure. In recent years, his work has shifted to more comprehensive interventions that have the potential to prevent the entire range of child and adolescent problems. He and colleagues at the Center for Advanced Study in the Behavioral Sciences published a book summarizing the epidemiology, cost, etiology, prevention, and treatment of youth with multiple problems (Biglan et al., 2004). He is a former president of the Society for Prevention Research. He was a member of the Institute of Medicine Committee on Prevention, which released its report in 2009 documenting numerous evidence-based preventive interventions that can prevent multiple problems. As a member of Oregon’s Alcohol and Drug Policy Commission, he is helping to develop a strategic plan for implementing comprehensive evidence-based interventions throughout Oregon. Episode link at https://neshnikolic.com/podcast/anthony-biglan   See omnystudio.com/listener for privacy information.

In Episode 25, we hear from Dr. Ramon R. Diaz-Arrastia, Professor of Neurology at the University of Pennsylvania. He discusses biological research regarding brain injury. Dr. Diaz-Arrastia also tells us about research projects that are currently being worked on, as well as what we can look forward to in the future. Dr. Diaz-Arrastia is Professor of Neurology at the University of Pennsylvania, where he leads the Traumatic Brain Injury Clinical Research Initiative. Dr. Diaz-Arrastia received his MD and PhD degrees from Baylor College of Medicine, and completed post-graduate training at Harvard and Columbia. Prior to coming to Penn, he served on the faculty at the University of Texas Southwestern, the Uniformed Services University of the Health Sciences, and the National Institute of Neurologic Disorders and Stroke (NINDS). Dr. Diaz-Arrastia has published over 200 primary research papers, as well as over 40 invited reviews and book chapters. He has also served in several national committees related to traumatic brain injury, epilepsy, and dementia, convened by the Institute of Medicine, the National Institutes of Health, the Department of Defense, and the Veterans Administration. He was a member of the Institute of Medicine Committee on the Public Health Dimensions of the Epilepsies.

Dr. Mary Rorro is the char of the Music and Medicine Committee for the American Medical Women's Association. Throughout this interview, Dr. Rorro shares with us just how important music is to any recovery process. From doing "music rounds" with her regular rounds in medical school, to helping Veterans learn a new instrument, to composing catchy tunes and beautiful pieces of music, Dr. Rorro has no doubt left a mark on all those she treats.

With our daily food now coming from around the world, keeping food safe needs to be a practice of prevention--at home and in commercial factories. Food safety and infectious disease expert Michael Osterholm helps to explain. About Michael Osterholm Michael Osterholm is the Regents Professor, McKnight Presidential Endowed Chair in Public Health, and the director of the Center for Infectious Disease Research and Policy at the University of Minnesota. He is a member of the National Academy of Medicine and the Council of Foreign Relations. In 2018 and 19, he served as science envoy for health security on behalf of the U.S. Department of State. He is the author of the 2017 book entitled Deadliest Enemy: Our War Against Killer Germs. He is widely regarded as a leading expert on infectious disease and recognized for his work far and wide.   Interview Summary Salmonella outbreak from eggs sickens 38 people in seven states. Ground beef producer issues recall due to deadly E. coli outbreak. Americans told to stop eating all romaine lettuce. General Mills' Gold Medal Unbleached flour is recalled over salmonella fears. These are but a few headlines and just from the past several months. Food safety outbreaks seem to be occurring more and more, with tragic consequences in some cases. Our guest, infectious disease epidemiologist Dr. Michael Osterholm, can explain why. Things have changed a lot with food policy over the years. Mike, when I was growing up, people spoke about trichinosis from not cooking pork sufficiently, but that was just about it. How's the picture different? Well, first of all, Kelly, thank you very much for having me on as a guest. It's a great honor. Let me just say that the epidemiology of foodborne disease has probably changed as much as any epidemiology or disease occurrence pattern in all the years I've been in this business. It's largely due to the fact that we eat very different foods today. When people say that we have the safest food supply in the world here in the United States, my response is we have the world's food supply. Today, we find food sourced from around the world. We find it produced in very different ways than it was 30 or 40 years ago where seasonal fruits and vegetables, leafy greens were just that seasonal. Today, we have them bring them 365 days a year. We chase the sun around the world often in low or middle income countries. We are very different about selection of what we have today. Thirty years ago in a grocery store, it was not unusual to have several thousand different choices to make. Today in the supermarket of the 21st century, we often see 65,000 to 100,000 different skews or potential items available. It's really the complexity and the location of where that food supply comes today that changes what it is that we're experienced with foodborne disease. Has that changed the likelihood that foodborne diseases will occur in outbreaks, or is it also affected the type of diseases that one gets transmitted through food? Well, we actually see both. It used to be that years ago, if one traveled to a developing world country or low income country, you worried about developing traveler's diarrhea. Today, you don't have to leave your home to develop traveler's diarrhea depending on what food item you're eating and how it is prepared. A good example is a parasitic disease called cyclospora. In this case, this is a disease that we often saw in low income and middle income countries. Today, we see it here now right in the United States occurring where product produced here. It's in part due to the fact that the workers likely play a major role in today. We see an ever changing complexion of who the workers are that are out in the fields doing the work to bring us our produce. We see this in terms of such things as a product like sprouts where today almost all the sprout seeds in the world actually come from outside the United States to make sprouts. Again, the potential for disease transmission is there, but we also see the complexity of even our U.S. system. For example, today in the ways that we grow cattle and pigs and poultry, we often see very large numbers of animals brought together in large confinement operations where a bacteria like E. coli or a virus like influenza in chickens can basically spread in such a way that it wasn't what we used to see when grandpa used to have the farm with 25 head of cattle. Even in the United States we see the potential for the development and the transmission of infectious agents very different. What are the most common foodborne illnesses and which are the most dangerous? Well, interestingly enough, it's actually in large part not due to production. In essence, if you look at the most common. Today, norovirus, which is a virus that causes vomiting and diarrhea 24 to 36 hours after exposure, is probably one of the leading pathogens we deal with and that is actually transplanted by food handler. But today, why is that important? Because we spend such a large proportion well up to half of all of our food dollars are spent eating out of the home and restaurants where again one sick food handler can transmit this virus to many, many different individuals with the type of food that they prepare. That's one thing. We do see, however, also a substantial number of salmonella inflections, camphylobacter, the kind of the E. coli bacteria infections that we often hear about with leafy green production. These are most often tied to production. They're tied to either contaminated water having contact with leafy greens or produce of some kind or transmission of salmonella or E. coli within cattle or poultry. These are all challenges today that we see in this country. How vulnerable are the major food companies to outbreaks would occur their products? Like we mentioned, General Mills Gold Medal Flour, that's a major company and a very common product. Are the companies legally liable for things that happened here? Are they reputationally liable? How are they vulnerable? Well, clearly food safety has become an ever increasingly complex issue to deal with. Surely these companies do realize that they are at risk. In most cases, we see companies doing everything they can that is reasonable to eliminate the risk of foodborne disease. For as many of the outbreaks that we hear about and the number of cases of disease, it's still a very, very small proportion. At most less than a percent of all meals ever result in a foodborne disease transmission in this country. We need to put that into perspective. It's just that when you have 300 million people eating three meals a day and munching a lot more in between that you have that potential for disease occurrence to happen. I think today we do have occasionally companies that are what I would call bad actors where they intentionally knew they had a problem and tended to cover it up. We've had some very notable ones with eggs, peanut butter, several companies where they falsified data to show that the product was safer than it really was by testing, but that's rare. That's very, very rare. On a whole, most companies are trying to do the right thing and they recognize the cost of not doing that both reputationally as you noted and as well as just strict liability. In the United States, where does the authority fall for testing and then monitoring food safety? Well, this is one of the challenges we have is is that there isn't one specific place. Food safety in this country has been carved up between the Food and Drug Administration, U.S. Department of Agriculture with some overlap in the Department of Commerce, for example, for seafood or talking about certain toxicological issues with the EPA. What we really need and I was part of the National Academy of Medicine at that time called the Institute of Medicine Committee some years ago that called for a single food safety agency in this country. I still support that very much. I think it would really dramatically improve our ability to respond. Today, for example, if you're a pizza manufacturing plant, if you basically have pizza and you put cheese on it, that falls under the FDA. But if you put cheese and meat on it, it falls under the USDA. There's real challenges in terms of trying to provide for a comprehensive coordinated effort. The same is true with the number of committees that varies from year to year, but as many as more than 20 committees on the hill in Congress has some authority over foodborne disease safety. That's a real challenge. To us right now, I think many of us would love to see a single food safety agency that would basically be fork to table. Then if an outbreak occurs, even including the investigative opportunity, to understand what's going on and stop it. Certainly seems to make sense. Why in the world hasn't it happened? Well, I think it's called territory. People all have government agency car gods where they have been doing this for years. There's congressional committees that don't want to give up their authority over this issue. Despite numerous recommendations to the contrary, we just don't seem to be able to get a single food safety agency, which I think would be a really of wise investment in food safety overall. I think the private sector would actually benefit from having a more comprehensive and coordinated food safety approach in this country. Mike, you alluded earlier to the fact that the food supply is so global. On a given day, one could eat foods that are coming in from a number of different countries. I imagine that makes monitoring even more complex. Is that right? It does. In fact, if you are actually requiring your food safety program to hinge on monitoring, you're already in trouble. What we've got to do is be out in the fields. We've got to be in the plants and making certain that we're doing everything we can to provide for the safest condition, good agricultural practices, good manufacturing practices. If you'd try to test your way out of a food safety problem, you're never going to do that. You just couldn't test enough product, and you've got to assure that that product's safe. Part of that is due to the fact not just the number of samples, but when we mass produce food today and we've been involved with outbreak where you can have many thousands of gallons of ice cream made or pounds of a product made, which the contamination is very, very sporadic. You could test it until you're blue in the face. You wouldn't pick up the contamination, but feed that to people who become the ultimate bioassay and you could have hundreds of thousands of cases with that mass produce food. Our job really is to also move food safety to the very origin of the food production process, to the fields, to wherever it may be and into the plants. That's hard to do and you have a very limited Food and Drug Administration with limited authority to be in other countries and that's where companies become very important. The secondary I just have to note has become an ever increasing challenge and it's one that is going to be even more of a challenge in the future related to climate change is water. The availability of potable water that's safe, that can be used for irrigation, that can be used for manufacturing, that can be used for washing equipment and hands and so forth is really a major issue for us around the world. I only see this becoming more and more of a problem as the availability of water and particularly potable water becomes more challenged with climate change. Mike, given that our listeners are living this day to day because we all eat, are there things people can do to minimize their risk? Well, I think first of all, the challenge we often see are not those of some mystery food, but just good hygiene in the kitchen. You have to assume that eggs are contaminated with salmonella or campylobacter. How many times in the kitchen do we forget that and we cross-contaminate our kitchens or we bring in raw meat, and we cut it on the cutting board, and then turn around and cut the salad up on that same cutting board. Just good safety practices in the kitchen themselves can be very, very important. The second thing is, again, buying food that is in a sense you might say from reputable sources. I mean, most of the major grocery stores and food sources today are buying from companies where they're putting the responsibility back on the food production companies to provide us a food supply. If they don't, they're not going to be sold. I think that it's clear that if you buy food from most grocery stores today, that's a safer bet than buying it from say unlicensed or unapproved sources. We see today more and more markets and so forth starting and that is a challenge in terms of assuring that food safety is being adhered to in those otherwise largely unregulated markets.

There is a new epidemiological reality in our country.  In 2018, the Centers for Disease Control announced for the second year in a row that life expectancy has fallen, driven in large part by suicides, drug overdoses, obesity, and chronic diseases. The term “diseases of despair” has been used to describe many of the conditions that are crippling our nation’s workforce and it is well-known that other developed nations outperform the United States in health rankings, despite our spending far more than other nations on health care.  In this episode, we’re talking about how these new realities and unmet needs are changing the nursing work environment and the important role nurses will play in the future of healthcare. GUEST Patricia (Polly) Pittman, PhD, FAAN is Professor of Health Policy and Management at the Milken Institute School of Public Health, with a secondary appointment in the School of Nursing, George Washington University. She serves as the Director of the Fitshugh Mullan Institute for Health Workforce Equity, and is the PI on two HRSA-supported Health Workforce Research Centers, focusing on (1) emerging workforce issues and (2) health equity in health professions’ education, respectively.  Trained in medical anthropology and public health, she is an expert on qualitative and mixed methods research designs focusing on delivery system changes.  She has published over 50 peer-reviewed journal articles and has served as PI on over 30 research grants relating to health workforce policy. These include a background paper commissioned by Robert Wood Johnson Foundation (RWJF) for the new National Academies of Medicine Committee on Nursing 2020-2030, and a series of studies that were commissioned to inform the 2010 Institute of Medicine’s Future of Nursing report. She teaches Advanced Health Policy Analysis and Health Workforce Policy in the GW School of Public Health.   HOST Alissa Brown, BSN, MSN, RN is a clinical nurse educator from the University of Utah Health. She has been working in the health care industry for almost 12 years, and started her nursing career as a med-surg bedside nurse on an Ortho, Trauma, and Surgical Specialty Unit. It was through that experience in the med-surg unit where she discovered a passion for education, and pursued a master’s degree. She is a lifelong learner, and loves to teach.  Born and raised in Salt Lake City, Utah, she's not all work, and definitely enjoys play! She loves to travel, and tries to plan as many vacations each year as she can with family and friends. Alissa loves to read, listen to podcasts, and geek out to documentaries and crime shows on the weekends. She's a total fair-weather fan when it comes to Utes Football, but will cheer in all the right places, or get mad when her husband tells her to during a game. Alissa is looking forward to conversations together on this AMSN podcast!  

------------------Support the channel------------ Patreon: https://www.patreon.com/thedissenter SubscribeStar: https://www.subscribestar.com/the-dissenter PayPal: paypal.me/thedissenter ------------------Follow me on--------------------- Facebook: https://www.facebook.com/thedissenteryt/ Twitter: https://twitter.com/TheDissenterYT Anchor (podcast): https://anchor.fm/thedissenter Dr. Anthony Biglan is a Senior Scientist at Oregon Research Institute and the Co-Director of the Promise Neighborhood Research Consortium. He has been conducting research on the development and prevention of child and adolescent problem behavior for the past several decades. His work has included studies of the risk and protective factors associated with tobacco, alcohol, and other drug use; high-risk sexual behavior; and antisocial behavior. He and colleagues at the Center for Advanced Study in the Behavioral Sciences published a book summarizing the epidemiology, cost, etiology, prevention, and treatment of youth with multiple problems, called Helping Adolescents at Risk (2004). He is a former president of the Society for Prevention Research. He was a member of the Institute of Medicine Committee on Prevention. He's also the author of The Nurture Effect: How the Science of Human Behavior Can Improve Our Lives and Our World. In this episode, we focus on some of the main topics of Dr. Biglan's book, The Nurture Effect. We refer to the role of evolution in the behavioral sciences, and to aspects of the environment from families to schools and societies, and the negative effects of coercive environments. We also discuss specifically addictive behaviors involving tobacco, alcohol and drugs, risky sexual behavior, and anti-social behavior. In the latter part of the interview, we also talk about cultural evolution, psychological flexibility, and their relationship to the development of nurturing socities. -- Follow Dr. Biglan's work: Faculty page: https://bit.ly/2tPIbcv Articles of Researchgate: https://bit.ly/2XxKX3p Values To Action: https://bit.ly/2TfFi3J Evolving a More Nurturing Capitalism: https://bit.ly/2tOIrs7 Association for Contextual Behavioral Science: https://bit.ly/2NODclz Association for Behavior Analysis International: https://bit.ly/2mQqzHY Society for Prevention Research: https://bit.ly/1CiEXuR The Evolution Institute: https://bit.ly/1MmXlbv Books: The Nurture Effect: How the Science of Human Behavior Can Improve Our Lives and Our World: https://amzn.to/2EoRwwt Evolution for Everyone: How Darwin's Theory Can Change the Way We Think About Our Lives: https://amzn.to/2NGekvV This View of Life: Completing the Darwinian Revolution: https://amzn.to/2ECm0LA -- A HUGE THANK YOU TO MY PATRONS: KARIN LIETZCKE, ANN BLANCHETTE, SCIMED, PER HELGE HAAKSTD LARSEN, LAU GUERREIRO, RUI BELEZA, MIGUEL ESTRADA, ANTÓNIO CUNHA, CHANTEL GELINAS, JIM FRANK, JERRY MULLER, FRANCIS FORD, HANS FREDRIK SUNDE, BRIAN RIVERA, ADRIANO ANDRADE, YEVHEN BODRENKO, SERGIU CODREANU, ADAM BJERRE, JUSTIN WATERS, AND ŁUKASZ STAFINIAK! A SPECIAL THANKS TO MY FIRST PRODUCER, Yzar Wehbe!

J. Lloyd Michener, MD, is Professor of Community and Family Medicine, Director of the Duke Center for Community Research, and Clinical Professor in the Duke School of Nursing. He co-chairs the Community Engagement Steering Committee for the Clinical Translation Science Awards of the NIH, and is a member of the Board of the Association of American Medical Colleges[AT2] . Dr. Michener is Past President of the Association for Prevention Teaching and Research and received the APTR Duncan Clark Award in 2013. He is also a past member of the Institute of Medicine Committee that led to the publication of “Primary Care and Public Health: Exploring Integration to Improve Population Health.” Dr. Michener is a steering committee member and principal investigator for The Practical Playbook.

During a golden age for scientific progress, a group of scientists were given free rein to do whatever they wanted to their human lab rats. We got new drugs, and learnt exciting new things. But some researchers took it too far... And what seemed like a scientific fantasy turned into one of the largest American science scandals. Check out the full transcript here: http://bit.ly/2MLBX6u Selected references: The 1976 report from the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research Allen Hornblum’s book Acres of Skin (1998)2007 report from the Institute of Medicine Committee on Ethical Considerations for Research The Experimental Scurvy in Man 1969 study  Credits: This episode was produced by Wendy Zukerman with help from Rose Rimler, Meryl Horn and Michelle Dang. Our senior producer is Kaitlyn Sawrey. We’re edited by Blythe Terrell and Caitlin Kenney. Fact checking by Michelle Harris and Michelle Dang. Mix and sound design by Peter Leonard. Music by Peter Leonard, Emma Munger and Bobby Lord. A huge thanks to all the researchers we got in touch with for this episode including Professor Karen Lebacqz, Michael Yesley. Also thanks to Sruthi Pinnamaneni, the Zukerman Family and Joseph Lavelle Wilson. 

This week on IAQ Radio we unveil a new feature we are calling “IAQradio+ Classics. In the past we have done Flashback Friday’s where we simply replayed a show from the archives. IAQradio Classics+ will be much more than a replay. IAQradio Classics+ are live shows with a video transcript of the show. We are having some of our best shows transcribed and will remix then to include the transcription. We start this week with a fantastic show with Dr. Harriet Ammann. Dr. Ammann holds a Ph.D. degree in Zoology and Biochemistry from North Carolina State University. She was a diplomate of the American Board of Toxicology from 1989 through 2014. She taught cell, human, vertebrate and comparative animal physiology for 14 years before joining the US EPA Hazardous Air Pollutant and Indoor Air Teams in 1984. She was senior toxicologist for Environmental Health of the Washington State Department of Health for 12 years, and then held the same position with the Air Quality Program of the Washington State Department of Ecology for 4 years. While interested in toxic effects from exposure for any exposure route, she is especially interested in inhalation and has worked extensively in indoor and ambient air pollution. She was a member of the NAS Institute of Medicine Committee on Damp Indoor Spaces and Health, and authored the microbial toxicity of the book published by the IOM. She has been working on public health issues since 1984. She is an affiliate associate professor in the Department of Environmental and Occupational Health Sciences at the School of Public Health of the University of Washington, Seattle, Washington. She teaches in courses in Toxicology and Community Air Pollution at the University, and teaches in Healthy Building courses on moisture, microbes and health in the indoor environment in Washington and in Oregon, and has presented on updates on asthma and the epidemiology and toxicology of indoor mold exposure at the Washington Department of Health Epidemiology Program, and for the Washington 2014 Asthma Summit. She will retire from her affiliate with the University of Washington School of Public Health in July, 2018

Wendy Chung, M.D., Ph.D. is a clinical and molecular geneticist who is the Director of Clinical Research at SFARI at the Simons Foundation and is the Kennedy Family Professor of Pediatrics and Medicine. She received her B.A. in biochemistry and economics from Cornell University, her M.D. from Cornell University Medical College, and her Ph.D. from The Rockefeller University in genetics. Chung also leads the Simons VIP study characterizing genetic forms of autism (https://simonsvipconnect.org/) and the SPARK study of autism (SPARKforAutism.org) and has a TED talk entitled Autism— what we know (and what we don't know yet) that has over 2 million views. Additionally, she was the recipient of the American Academy of Pediatrics Young Investigator Award and the Medical Achievement Award from Bonei Olam. Additionally, Dr. Chung was the original plaintiff in the Supreme Court case that overturned the ability to patent genes and is a member of the the Institute of Medicine Committee on Genetic Testing.   All Autism Talk is sponsored by Autism Spectrum Therapies, Trellis Services and Learn It Systems.

Dr. Tom Trabin is now in his 24th consecutive year of organizing and chairing a national conference and trade show on how information systems can help improve care for persons with mental health and substance use disorders. The conference features presentations on the challenges and opportunities presented by electronic health record systems, the most current developments in electronic health information exchange including privacy and security issues, and the practical uses of data for management and clinical decision making. Dr. Trabin is a licensed psychologist with extensive experience in policy making, management, and clinical services within the behavioral health care field.  He currently serves as Deputy Director of the California Drug Medi-Cal External Quality Review Organization, working to support the effective implementation of organized delivery systems for substance use treatment throughout California. Dr. Trabin worked to design and promote national standards for performance measures, electronic and personal health records, and health information exchange through federal agencies and accrediting organizations, and prominent standard-setting organizations. Dr. Trabin served on the Institute of Medicine Committee that produced the groundbreaking Improving the Quality of Healthcare for Mental Health and Substance Use Conditions. He is active in statewide committees that help formulate the design and implementation of California’s substance use treatment systems of care. He organized and chaired over 30 national and statewide conferences; produced over 60 professional publications including several books; and presented at over 150 international, national and state conferences.   

This week my guest is Anthony Biglan, PhD author of The Nurture Effect: How the Science of Human Behavior Can Improve Our Lives and Our World. About the book: A fascinating look at the evolution of behavioral science, the revolutionary way it’s changing the way we live, and how nurturing environments can increase people’s well-being in virtually every aspect of our society, from early childhood education to corporate practices. If you want to know how you can help create a better world, read this book. What if there were a way to prevent criminal behavior, mental illness, drug abuse, poverty, and violence? Written by behavioral scientist Tony Biglan, and based on his ongoing research at the Oregon Research Institute, The Nurture Effect offers evidence-based interventions that can prevent many of the psychological and behavioral problems that plague our society. For decades, behavioral scientists have investigated the role our environment plays in shaping who we are, and their research shows that we now have the power within our own hands to reduce violence, improve cognitive development in our children, increase levels of education and income, and even prevent future criminal behaviors. By cultivating a positive environment in all aspects of society—from the home, to the classroom, and beyond—we can ensure that young people arrive at adulthood with the skills, interests, assets, and habits needed to live healthy, happy, and productive lives. The Nurture Effect details over forty years of research in the behavioral sciences, as well as the author’s own research. Biglan illustrates how his findings lay the framework for a model of societal change that has the potential to reverberate through all environments within society. About the author: Anthony Biglan, PhD, is a senior scientist at Oregon Research Institute and a leading figure in the development of prevention science. His research over the past thirty years has helped to identify effective family, school, and community interventions to prevent all of the most common and costly problems of childhood and adolescence. He is a leader in efforts to use prevention science to build more nurturing families, schools, and communities throughout the world. Biglan lives in Eugene, Oregon. In recent years, his work has shifted to more comprehensive interventions that have the potential to prevent the entire range of child and adolescent problems. He and colleagues at the Center for Advanced Study in the Behavioral Sciences published a book summarizing the epidemiology, cost, etiology, prevention, and treatment of youth with multiple problems. He is a former president of the Society for Prevention Research. He was a member of the Institute of Medicine Committee on Prevention, which released its report in 2009 documenting numerous evidence-based interventions that can prevent multiple problems.

Episode # 37 Running time: 1:01:37 Podcast relevance: Professionals and Consumers In this episode, Trent Codd interviews Anthony Biglan, Ph.D. the author of The Nurture Effect: How the Science of Human Behavior Can Improve Our Lives and Our World. Specifically, they discuss: how to create family, school, workplace, and community environments that nurture wellbeing the power a small set of core principles can have in preventing many mental health and behavioral problems why and how capitalism has evolved in a direction that has increased economic inequality and poverty Biography Anthony Biglan, Ph.D. is a Senior Scientist at Oregon Research Institute. He has been conducting research on the development and prevention of child and adolescent problem behavior for the past 30 years. His work has included studies of the risk and protective factors associated with tobacco, alcohol, and other drug use; high-risk sexual behavior; and antisocial behavior. He has conducted numerous experimental evaluations of interventions to prevent tobacco use both through school-based programs and community-wide interventions. And, he has evaluated interventions to prevent high-risk sexual behavior, antisocial behavior, and reading failure. In recent years, his work has shifted to more comprehensive interventions that have the potential to prevent the entire range of child and adolescent problems. He and colleagues at the Center for Advanced Study in the Behavioral Sciences published a book summarizing the epidemiology, cost, etiology, prevention, and treatment of youth with multiple problems (Biglan et al., 2004). He is a former president of the Society for Prevention Research. He was a member of the Institute of Medicine Committee on Prevention, which released its report in 2009 documenting numerous evidence-based interventions that can prevent multiple problems.   To learn more about the book please visit: www.NurtureEffect.com    

In this War on Poverty Conference presentation, Greg Duncan discusses Douglas Miller’s paper “Long Run Puzzles in Head Start Research." The Center for Poverty Research hosted the conference at UC Davis on Jan. 9 and 10, 2014. Duncan is an economist and Distinguished Professor in the Department of Education at the University of California, Irvine. He currently serves as chair of a National Research Council’s Institute on Medicine Committee on child research

Dr. Olugbenga Ogedegbe is an Associate Professor of Medicine and the Director of the Center for Healthful Behavior Change in the NYU School of Medicine's Division of General Internal Medicine. The programmatic focus of Dr. Ogedegbe's research is the translation and dissemination of evidence-based behavioral interventions targeted at cardiovascular risk reduction. His work focuses on translational behavioral medicine, addressing the T2/T3 gaps in translation research. Dr. Ogedegbe has extensive experience in the implementation of clinical trials of behavioral and lifestyle interventions targeted at medication adherence and blood pressure control in primary care practices and community-based settings. He is Principal Investigator on several NHLBI-funded R01 community and practice-based clinical trials, Project Leader on two NCMHHD-funded Health Disparities Center, and Co-Investigator on several NIH-funded trials in diabetes management and sleep disorders. Dr. Ogedegbe has served on several NIH study sections, is a permanent member of the Behavior Medicine Intervention and Outcomes study section and several special emphasis panels at the NHLBI, NCI, and the NCMHHD, as well as a member of the Eighth Joint National Committee on the Detection, Evaluation, Prevention and Treatment of Hypertension, and The Institute of Medicine Committee on Living Well with Chronic Disease.